Campaign targets Aussies in their 50s at risk of AMD

Australian of the Year and ophthalmologist Dr James Muecke has endorsed a new campaign aimed at motivating Australians in their 50s to have a macula check after it was revealed most in this age group are unable to identify macular disease risk factors. Read more

Aussie firm reveals next-gen MIGS device in pipeline

Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for its 2RT laser therapy for intermediate AMD that could fulfil a distinct gap in a multi-billion-dollar market. Read more

TGA approves Luxturna gene therapy

In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true gene therapy, indicated for a rare form of inherited retinal disease (IRD). Read more

Clinical model puts dry eye first

In the final instalment of Insight’s five-part dry eye series, optometrist Ms Marilyn Stern reveals how low overheads and no refraction equipment set Perth’s first dedicated dry eye clinic apart. So too does its patient demographic, with several teens counted among them. Read more

© All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited